Ocular Manifestations of GLP-1/GLP-1 + GIP Drugs
Tracking # 20-1345938
Price not reported
Course overview
GLP-1 receptor agonists are widely prescribed for the management of Type 2 diabetes and obesity. Numerous reports have cited ocular side effects associated with their usage. The most frequently reported complications include non-arteritic ischemic optic neuropathy, diabetic retinopathy, links to macular complications, changes in intraocular pressure, refractive shifts and dry eye. Overall, while GLP-1RAs provide significant systemic benefits, careful ophthalmic monitoring, particularly in high-risk patients is recommended. This course will review the pathophysiology of GLP-1 RAs and investigate the link between these medications and ocular side effects. Case examples will be highlighted.
Subject areas
This course counts toward the state boards and subject areas below.